Hazel Joan Dyke

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
F. HOFFMANN-LA ROCHE AG
1
2
2010
2011
O2MICRO, INC.
1
1996
GLAXO WELLCOME INC.
1
1
2000
2002
HELPERBY THERAPEUTICS LIMITED
2
2
2
1
2006
2008
2012
2017
ARGENTA DISCOVERY LIMITED
1
2003
UCB PHARMA S.A.
1
3
2002
2004
CELLTECH R&D LIMITED
1
2002
Genentech, Inc.
5
2
3
2
3
2
2007
2008
2009
2013
2014
2015
ZAFGEN, INC.
3
8
2
2011
2012
2015
PAINCEPTOR PHARMA CORPORATION
2
2007
GLAXOSMITHKLINE LLC
2
2002
DARWIN DISCOVERY LIMITED
2
5
1
4
12
3
1
1996
1997
1998
1999
2001
2002
2003
CHIROSCIENCE LIMITED
1
1996
ALMAC DISCOVERY LIMITED
2
2010
ASTRAZENECA AB
1
2004
SMITHKLINE BEECHAM CORPORATION
1
2
2000
2001
THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
2
2
3
2
2
2
2008
2009
2010
2011
2012
2016

Inventor Addresses

AddressDuration
Cambridge, GBMar 17, 98 - Aug 23, 05
Essex, GBSep 30, 04 - Dec 03, 19
Harlow Essex, GBOct 25, 07 - Oct 25, 07
Harlow, GBJan 03, 08 - Feb 07, 17
Harlow, UKOct 03, 13 - Oct 03, 13
Hempstead, GBMar 21, 06 - Mar 21, 06
Saffron Walden, GBJun 05, 03 - Jun 05, 03
Safron, Walden, GBOct 26, 06 - Oct 26, 06
Storrington, GBJul 28, 11 - Dec 05, 17
Walden, GBDec 07, 06 - Dec 07, 06

Technology Profile

Technology Matters
A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 7
A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS 1
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 67

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
104930712019Use of pyrroloquinoline compounds to kill clinically latent microorganisms7
983454920173,3-disubstituted-(8-aza-bicyclo[3.2.1]OCT-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (β)-HSD10
2017/0258,7842017USE OF PYRROLOQUINOLINE COMPOUNDS TO KILL CLINICALLY LATENT MICROORGANISMS0
96940062017Use of pyrroloquinoline compounds to kill clinically latent microorganisms10
95612302017Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.